Search results
Fauci, other top health officials receive Moderna Covid-19 vaccine on camera
AOL· 2 hours agoFauci, director of the National Institute of Allergy and Infectious Diseases, received the shot...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via AOL· 5 days agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 4 days agoThe Covid vaccines, a triumph of science and public health, are estimated to have prevented millions...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 4 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
How mRNA vaccines could be personalized cancer cures
Axios· 4 hours agoWhy it matters: This personalized approach could make conditions...pancreatic and breast cancers treatable, and even potentially preventable, via...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 23 hours agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 5 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 5 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 5 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 5 days agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...